Detalhe da pesquisa
1.
Comparison of Large Language Models in Answering Immuno-Oncology Questions: A Cross-Sectional Study.
Oncologist
; 29(5): 407-414, 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38309720
2.
Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses.
J Transl Med
; 22(1): 524, 2024 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38822345
3.
Utility of Large Language Models for Health Care Professionals and Patients in Navigating Hematopoietic Stem Cell Transplantation: Comparison of the Performance of ChatGPT-3.5, ChatGPT-4, and Bard.
J Med Internet Res
; 26: e54758, 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38758582
4.
Phase 1 trial of CV301 in combination with anti-PD-1 therapy in nonsquamous non-small cell lung cancer.
Int J Cancer
; 152(3): 447-457, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36054490
5.
Bintrafusp Alfa: A Bifunctional Fusion Protein Targeting PD-L1 and TGF-ß, in Patients with Pretreated Colorectal Cancer: Results from a Phase I Trial.
Oncologist
; 28(2): e124-e127, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36576431
6.
Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-ß and PD-L1, in Patients With Non-Small Cell Lung Cancer Resistant or Refractory to Immune Checkpoint Inhibitors.
Oncologist
; 28(3): 258-267, 2023 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36571770
7.
Avelumab in Patients With Metastatic Colorectal Cancer.
Oncologist
; 28(9): 823-e804, 2023 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37310790
8.
A Phase I Single-Arm Study of Biweekly NHS-IL12 in Patients With Metastatic Solid Tumors.
Oncologist
; 28(4): 364-e217, 2023 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36640137
9.
Flutamide With or Without PROSTVAC in Non-metastatic Castration Resistant (M0) Prostate Cancer.
Oncologist
; 28(7): 642-e561, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37134294
10.
The NIH pediatric/young adult chordoma clinic and natural history study: Making advances in a very rare tumor.
Pediatr Blood Cancer
; : e30358, 2023 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37347686
11.
HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study.
Lancet Oncol
; 23(1): 172-184, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34895481
12.
Joint-Predominant Rheumatic Complications of Immune Checkpoint Inhibitor Therapy in Patients with Thymic Epithelial Tumors.
Oncologist
; 27(4): e353-e356, 2022 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35380721
13.
A Single-arm Phase II Study Combining NLG207, a Nanoparticle Camptothecin, with Enzalutamide in Advanced Metastatic Castration-resistant Prostate Cancer Post-Enzalutamide.
Oncologist
; 27(9): 718-e694, 2022 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35640474
14.
A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer.
Oncologist
; 27(3): 198-209, 2022 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35274710
15.
Long-term avelumab in advanced non-small-cell lung cancer: summaries and post hoc analyses from JAVELIN Solid Tumor.
Future Oncol
; 18(11): 1333-1342, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35144482
16.
Randomized, Double-Blind, Placebo-Controlled Phase II Study of Yeast-Brachyury Vaccine (GI-6301) in Combination with Standard-of-Care Radiotherapy in Locally Advanced, Unresectable Chordoma.
Oncologist
; 26(5): e847-e858, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33594772
17.
Cabozantinib plus docetaxel and prednisone in metastatic castration-resistant prostate cancer.
BJU Int
; 127(4): 435-444, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32969563
18.
Resistance to Immunotherapy: Mechanisms and Means for Overcoming.
Adv Exp Med Biol
; 1342: 45-80, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34972962
19.
Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial.
Lancet Oncol
; 21(8): 1099-1109, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32645282
20.
Endocrine-Related Adverse Events Related to Immune Checkpoint Inhibitors: Proposed Algorithms for Management.
Oncologist
; 25(4): 290-300, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32297436